|
|
||||||||
Eur J Cardiothorac Surg 2005;27:662-666
© 2005 Elsevier Science NL
Section of General Thoracic Surgery, Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Received 15 September 2004; received in revised form 30 November 2004; accepted 6 December 2004.
* Corresponding author. Address: Division of Thoracic Surgery, Georgetown University Hospital, 4 PHC, 3800 Reservoir Rd NW, Washington, DC 20007, USA. Tel.: +1 202 444 5045; fax: +1 202 444 3057. (E-mail: mbm5{at}gunet.georgetown.edu).
| Abstract |
|---|
|
|
|---|
Key Words: Pneumothorax Spontaneous pneumothorax Endometriosis Hormonal therapy Video assisted thoracic surgery
| 1. Introduction |
|---|
|
|
|---|
The treatment for CP is directed towards the management of the pneumothorax and the prevention of its recurrence. As many of the patients have a diagnosis of pelvic endometriosis, hormonal therapy may also have a role in the management of CP as well. The impact of various hormonal therapies on CP is, however, unknown.
In order to evaluate the prevalence, presentation, effectiveness of hormonal therapy and results of surgical therapy, we performed a retrospective review of female patients presenting with recurrent pneumothorax at a single institution.
| 2. Materials and methods |
|---|
|
|
|---|
| 3. Results |
|---|
|
|
|---|
3.1. Hormonal manipulation
All eight patients received some form of hormonal treatment at some time. Patients were placed on hormonal therapy by their gynecologist, prior to being referred to a thoracic surgeon. All six patients taking hormonal replacement pre-operatively (five oral and one transdermal), had recurrent pneumothoraces while on this therapy. Patients were on this therapy for the management of associated symptoms of endometriosis (1), for contraception (2) or for the prevention of catamenial penumothorax (3). Two patients, one with almost monthly episodes of CP, were placed on a gonadotropin-releasing hormone (GnRH) agonist pre-operatively specifically to manage their CP. They did not have a recurrence while on this drug. Three patients were on hormonal replacement post-operatively and two of these had recurrences while taking these medications. In one patient, this was after a total abdominal hysterectomy and bilateral salpingooophorectomy. This patient was on hormonal replacement for the management of hormonal withdrawal symptoms. Three patients received a GnRH agonist post-operatively. One patient stopped this therapy after 1 month due to side effects and subsequently developed recurrent CP. No patients had a recurrence while taking a GnRH agonist either pre-operatively or post-operatively.
3.2. Intra-operative findings/surgical management
Of eight patients treated for catamenial pneumothorax, thoracoscopic evaluation confirmed diaphragmatic endometrial implants in five (Fig. 1). One patient had an endometrial implant visible on their visceral pleural surface (Fig. 2). Diaphragmatic fenestrations were observed in four of the five patients with diaphragmatic endometrial implants. Two patients had apical blebs in addition to one or more of the previously described findings. Two patients did not have any identifiable intra-thoracic pathology at the time of initial thoracoscopy. One of these had parenchymal implants observed at a repeat procedure for recurrent CP and failed pleurodesis (Table 1).
|
|
|
Three patients recurred post-operatively. One had a loculated basilar pneumothorax and was successfully managed with a catheter and doxycycline pleurodesis. A GnRH agonist was recommended to the second patient, but she chose a hysterectomy with bilateral salpingooophorectomy. She was placed on hormonal therapy to control hot flashes and had recurrent CP with this. She subsequently underwent repeat thoracoscopy with pleurectomy. At the repeat procedure, no adhesions were observed. Visceral parenchymal endometrial implants were identified and resected. This patient subsequently recurred again with a loculated pneumothorax along the diaphragm. A small catheter was placed and the basilar space was pleurodesed with doxycycline. The third patient had a small pneumothorax and was managed conservatively. Other than recurrence, there were no post-operative complications. Three of eight patients currently have chronic catamenial chest pain without radiographic abnormalities.
Follow-up ranged from 27 to 63 months with a mean 48 months (Table 1). Asymptomatic patients were followed yearly and patients with a recurrence were evaluated at the onset of symptoms. In addition, a telephone interview was obtained from all patients at the time of data collection.
| 4. Discussion |
|---|
|
|
|---|
Historically, CP has been considered a rare cause of spontaneous pneumothorax. The reported incidence of catamenial pneumothorax is only 2.85.6% in women suffering from spontaneous pneumothoraces [3]. Our series and a recent prospective study of catamenial pneumothorax would suggest that the incidence is actually much higher [4]. We found CP to be the cause of pneumothorax in eight of 24 (33%). This may reflect increased awareness of this pathology with more directed history taking and careful visual inspection at the time of surgery.
Despite the fact that CP has been known to exist for almost half a century, the etiology has not been clearly defined. Endometriosis has often been blamed for the initiation of the sequence of events in this condition, though the existence of associated pelvic endometriosis has been accounted for in only 2070% of patients with catamenial pneumothorax [5,6]. A pre-operative history of pelvic endometriosis was identified in 50% of our patients with CP. As of yet, a history of pelvic endometriosis has not been shown to play a specific role in the development or prevention of CP, so we do not recommend additional interventions looking for this pathology in asymptomatic patients with the diagnosis of CP.
Although no single theory can explain all of the findings in either endometriosis or CP, there are three extant theories of the pathogenesis of CP that may be relevant to CP:
In our series, diaphragmatic implants were observed in five of eight patients. Frank diaphragmatic fenestrations were observed in 50% of the patients in our series; all patients with fenestrations also had diaphragmatic endometrial implants. This, and the fact that endometrial tissue has been observed at the borders of the defects [12], would suggest that endometrial implants are the cause for the fenestrations.
Catamenial pneumothorax has a predominant right sided occurrence (100% in our series in the vicinity of 90% in others) [1,4,6]. The preference for the right hemi-diaphragm is attributed by some to the well-described piston effect exerted by the liver [13]. Visceral pleural implants were observed in 1/8 of our patients initially, and in a second patient at a repeat procedure. The presence of intra-parenchymal endometrial implants observed by others in CP, as well as catamenial hemoptysis, is best supported by the metastatic hypothesis. This also explains endometrial tissue reported in distant regions such as the eye, knee, and brain [5,9].
There is a wide variation in the prevalence of diaphragmatic fenestrations with endometrial implants in patients with CP, 2388% [1,14,15]. As previously mentioned, in our series, every patient with diaphragmatic fenestrations also had diaphragmatic endometrial implants, strongly suggesting that the latter causes the former.
It has been hypothesized that elevated levels of prostaglandins in the peri-menstrual period might sensitize pulmonary blebs and make them more prone to rupture [16]. In our study, apical blebs were identified and resected in two patients (25%). However, at the time of surgery, none of the blebs appeared to have ruptured, and both of these patients also had parenchymal or diaphragmatic implants (Table 1). Further, in spite of undergoing complete excision of their bullous disease, one patient had recurrent CP following surgical treatment.
Endometrial parenchymal and/or diaphragmatic implants were observed in 6/8 patients at the initial operation and one additional patient with parenchymal implants identified at a second operation (Table 1). Also, 6/8 patients had multiple sites of pathology identified. The proportion of findings do not appear to be related to the severity of disease or risk for recurrence as two of the three patients who recurred had no pathology identified at the time of initial thoracoscopy. As 7/8 patients (87%) had either diaphragmatic or visceral pleural implants identified, our data strongly supports Sampson's theory as the predominant etiology of CP.
Our data further demonstrate that hormonal therapies that allow for menses do not prevent CP, even in patients who have had a hysterectomy with bilateral salpingooophorectomy. There were no CP observed in patients receiving the GnRH agonist, Lupron. This drug appears to effectively suppress CP and may be of use in the peri-operative management of these patients. Pre-operative patients, who are not going to surgery with-in their current cycle, or post-operative patients, to allow for maturation of adhesions before challenging the pleurodesis, may benefit from this therapy. We do not recommend long term management of CP with this drug because it is poorly tolerated and the long term effects of chronic hormonal ablation in pre-menopausal women is unknown.
Finally, regarding surgical technique, some have reported that pleural abrasion alone is necessary for the management of CP. We would argue on the contrary, that as much of the pathology be addressed as possible through a minimally invasive approach. Apical blebs and parenchymal implants should be resected. Diaphragmatic fenestrations should be excised or closed. Additionally, because of the high recurrence rate observed, we would agree with others that an additional procedure to specifically address the risk of basilar recurrence should be performed [10,17]. Polygalactin mesh placed on the diaphragm appears to augment pleurodesis in this difficult area [10]. Another option is the selective use of talc along the diaphragmatic surface, as one surgeon used in this series. However, it is unclear if the potential risks of intrapleural talc outweigh the benefits in this young population. Certainly, the standard mechanical pleurodesis that most surgeons perform does not sufficiently address the diaphragmatic surface, which we and others find to be the location of the majority of the pathology in CP and the site of many recurrences.
| 5. Conclusion |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P. Ciriaco, G. Negri, L. Libretti, A. Carretta, G. Melloni, M. Casiraghi, A. Bandiera, and P. Zannini Surgical treatment of catamenial pneumothorax: a single centre experience Interactive CardioVascular and Thoracic Surgery, March 1, 2009; 8(3): 349 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rafay, H. El-Bawab, W. Kurdi, and K. Al Kattan Diaphragmatic Fenestrations in Catamenial Pneumothorax: a Management Strategy Asian Cardiovasc Thorac Ann, January 1, 2009; 17(1): 70 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bagan, P. Berna, J. Assouad, V. Hupertan, F. Le Pimpec Barthes, and M. Riquet Value of cancer antigen 125 for diagnosis of pleural endometriosis in females with recurrent pneumothorax Eur. Respir. J., January 1, 2008; 31(1): 140 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alifano, C. Jablonski, H. Kadiri, P. Falcoz, A. Gompel, S. Camilleri-Broet, and J.-F. Regnard Catamenial and Noncatamenial, Endometriosis-related or Nonendometriosis-related Pneumothorax Referred for Surgery Am. J. Respir. Crit. Care Med., November 15, 2007; 176(10): 1048 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vercellini, A. Abbiati, P. Vigano, E.D. Somigliana, R. Daguati, F. Meroni, and P.G. Crosignani Asymmetry in distribution of diaphragmatic endometriotic lesions: evidence in favour of the menstrual reflux theory Hum. Reprod., September 1, 2007; 22(9): 2359 - 2367. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |